IRIS
CERIELLO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.413
AS - Asia 6.602
EU - Europa 4.384
SA - Sud America 1.618
AF - Africa 153
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 5
Totale 33.189
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.255
SG - Singapore 3.354
UA - Ucraina 1.601
BR - Brasile 1.260
CN - Cina 1.186
DE - Germania 772
FI - Finlandia 667
HK - Hong Kong 640
VN - Vietnam 561
RU - Federazione Russa 331
FR - Francia 259
IE - Irlanda 253
SE - Svezia 179
KR - Corea 161
AR - Argentina 158
TR - Turchia 144
IN - India 129
GB - Regno Unito 98
BD - Bangladesh 88
IT - Italia 87
CA - Canada 69
IQ - Iraq 66
ZA - Sudafrica 50
CO - Colombia 49
EC - Ecuador 48
ID - Indonesia 48
MX - Messico 41
PK - Pakistan 41
VE - Venezuela 30
MA - Marocco 25
ES - Italia 20
PY - Paraguay 20
TN - Tunisia 20
UZ - Uzbekistan 20
CL - Cile 18
NL - Olanda 17
JP - Giappone 16
PE - Perù 15
PL - Polonia 15
UY - Uruguay 15
BE - Belgio 14
EU - Europa 14
SA - Arabia Saudita 14
KZ - Kazakistan 13
IR - Iran 12
KE - Kenya 12
PH - Filippine 12
AE - Emirati Arabi Uniti 11
EG - Egitto 11
MY - Malesia 11
AT - Austria 10
DZ - Algeria 10
JO - Giordania 10
OM - Oman 10
TW - Taiwan 10
JM - Giamaica 9
PT - Portogallo 9
CH - Svizzera 7
CR - Costa Rica 6
DO - Repubblica Dominicana 6
AZ - Azerbaigian 5
BH - Bahrain 5
BO - Bolivia 5
CZ - Repubblica Ceca 5
GT - Guatemala 5
LB - Libano 5
LT - Lituania 5
RS - Serbia 5
HN - Honduras 4
HU - Ungheria 4
KG - Kirghizistan 4
PA - Panama 4
AL - Albania 3
AU - Australia 3
BA - Bosnia-Erzegovina 3
BS - Bahamas 3
BY - Bielorussia 3
EE - Estonia 3
GE - Georgia 3
IL - Israele 3
NG - Nigeria 3
NI - Nicaragua 3
NP - Nepal 3
PS - Palestinian Territory 3
RO - Romania 3
AM - Armenia 2
BB - Barbados 2
BG - Bulgaria 2
CG - Congo 2
CI - Costa d'Avorio 2
CM - Camerun 2
ET - Etiopia 2
GA - Gabon 2
GR - Grecia 2
MD - Moldavia 2
MM - Myanmar 2
MU - Mauritius 2
PR - Porto Rico 2
SN - Senegal 2
SV - El Salvador 2
Totale 33.162
Salva come PNG Salva come JPEG
Città #
Woodbridge 3.298
Fairfield 2.612
Ann Arbor 2.388
Houston 1.872
Ashburn 1.288
Jacksonville 1.186
Seattle 1.006
Singapore 992
Wilmington 927
Cambridge 925
Hong Kong 631
Dearborn 554
Beijing 531
Chandler 528
San Jose 310
Boardman 297
Princeton 265
Dublin 252
Lauterbourg 234
Ho Chi Minh City 213
Hefei 158
Seoul 151
Los Angeles 145
San Diego 140
Helsinki 131
Hanoi 125
Buffalo 122
Izmir 116
Dallas 106
São Paulo 102
Munich 100
The Dalles 97
New York 57
Ogden 56
Norwalk 49
Redondo Beach 46
Rio de Janeiro 44
Council Bluffs 43
Ottawa 42
Des Moines 41
San Mateo 35
Belo Horizonte 31
Haiphong 31
Nanjing 30
Grafing 27
Frankfurt am Main 26
Baghdad 25
Brasília 25
Nuremberg 24
Porto Alegre 24
Johannesburg 22
Kunming 22
Udine 21
Orem 20
Campinas 18
Da Nang 18
Guangzhou 18
Mumbai 18
Quito 18
Dhaka 17
Tashkent 17
Curitiba 16
Guayaquil 16
Nanchang 16
Salvador 16
Chicago 15
Denver 15
Santa Clara 15
Bogotá 14
Buenos Aires 14
Ribeirão Preto 14
Tokyo 14
Warsaw 14
Hải Dương 13
Jinan 13
Charlotte 12
Medellín 12
Andover 11
Can Tho 11
Guarulhos 11
Hull 11
Mexico City 11
Sorocaba 11
São José do Rio Preto 11
Toronto 11
Brussels 10
Chennai 10
Lahore 10
Leawood 10
Lima 10
Nairobi 10
Ninh Bình 10
Osasco 10
Phoenix 10
Santo André 10
Thái Bình 10
Wuhan 10
Atlanta 9
Biên Hòa 9
Caracas 9
Totale 23.131
Salva come PNG Salva come JPEG
Nome #
Deficient antithrombin III activity and enhanced fibrinolysis in patients with liver disease: Evidence against a cause-effect relationship 250
Possible role of oxidative stress in the pathogenesis of hypertension. 228
Oxidative stress and diabetes-associated complications. 215
Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat 202
Anti-oxidants show an anti-hypertensive effect in diabetic and hypertensive subjects. 187
The oxygen-release capacity of red blood cells in insulin-dependent diabetics after artificial pancreas. 181
Intra-arterial iloprost for limb ischaemia. 181
Increased prothrombin fragment 1 + 2 in type I diabetic patients. 178
Administration of a new diabetes-specific enteral formula results in an improved 24h glucose profile in type 2 diabetic patients. 178
The metabolic syndrome--a postprandial disease? 174
Acute hyperglycaemia and oxidative stress generation. 170
Does a common mechanism induce diverse complications of diabetes? 169
Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update. 168
Antioxidant defences are reduced during the oral glucose tolerance test in normal and non-insulin-dependent diabetic subjects. 166
Antioxidant therapy in diabetic complications: what is new? 165
Fibrinogen plasma levels as a marker of thrombin activation: new insights on the role of fibrinogen as a cardiovascular risk factor 163
Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation 162
D-lysine and non-enzymatic glycation. 162
'Glycaemic variability': a new therapeutic challenge in diabetes and the critical care setting. 162
High glucose induces antioxidant enzymes in human endothelial cells in culture. Evidence linking hyperglycemia and oxidative stress. 160
Pregnancy as environmental factor precipitating IDDM. 160
Total radical-trapping antioxidant parameter in NIDDM patients. 160
Postprandial oxidized lipids in diabetic patients: which role for postprandial hyperglycemia? 159
Antioxidant anti-inflammatory treatment in type 2 diabetes. 158
Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. 158
Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human Umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production 157
Mean red blood cell volume, narcotic addiction, and glucose tolerance 156
Decreased antithrombin III activity in diabetes may be due to non-enzymatic glycosylation--a preliminary report. 156
Inhibitory effect of enkephalin on insulin secretion in healthy subjects and in non insulin-dependent diabetic subjects. 155
Reactive oxygen species mediate a cellular 'memory' of high glucose stress signalling. 155
Aspirin and non-enzymatic glycation. 154
Guideline for management of postmeal glucose. 154
Congestive heart failure and cognitive impairment in the elderly. 154
Meal-generated oxidative stress in diabetes. The protective effect of red wine. 153
Controlling oxidative stress as a novel molecular approach to protecting the vascular wall in diabetes. 153
Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome. 153
Meal-generated oxidative stress in type 2 diabetic patients 152
Sodium salicylate restores the impaired insulin response to glucose and improves glucose tolerance in heroin addicts. 152
Prevention of vascular events in diabetes mellitus: which "antithrombotic" therapy? 152
Macromolecular protein complex: a new way to understand the fibrinogen lowering effect of glycosaminoglycans? 151
Increased glycosylated proteins in opiate addicts. 151
Advanced glycation end products and antioxidant status in type 2 diabetic patients with and without peripheral artery disease. 151
Identifying patients with type 2 diabetes at high risk of microalbuminuria: results of the DEMAND (Developing Education on Microalbuminuria for Awareness of reNal and cardiovascular risk in Diabetes) Study. 151
Postprandial glucose regulation: new data and new implications. 151
Glutathione reverses systemic hemodynamic changes induced by acute hyperglycemia in healthy subjects. 150
Thiazolidinediones as anti-inflammatory and anti-atherogenic agents. 150
Evaluation of gliclazide ability to attenuate the hyperglycaemic 'memory' induced by high glucose in isolated human endothelial cells. 150
Point: postprandial glucose levels are a clinically important treatment target. 150
Impaired glucose metabolism in heroin and methadone users. 149
Endogenous opiates, heroin addiction, and non-insulin-dependent diabetes. 149
Post-meal coagulation activation in diabetes mellitus: the effect of acarbose. 149
Non-enzymatic glycosylation reduces antithrombin III activity 149
Detection of nitrotyrosine in the diabetic plasma: evidence for oxidative stress 148
Diabetes mellitus and hypertension: the possible role of hyperglycaemia through oxidative stress. 147
Effects of S 21403 (mitiglinide) on postprandial generation of oxidative stress and inflammation in type 2 diabetic patients 147
A long-term "memory" of HIF induction in response to chronic mild decreased oxygen after oxygen normalization. 147
Atypical environmental factor in expressing type I (insulin-dependent) diabetes mellitus. 147
Red wine protects diabetic patients from meal-induced oxidative stress and thrombosis activation: a pleasant approach to the prevention of cardiovascular disease in diabetes. 146
New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. 146
Tolrestat for mild diabetic neuropathy. A 52-week, randomized, placebo-controlled trial. 146
Evidence for a reduced heparin cofactor II biological activity in diabetes. 146
Angiotensin-receptor blockers, type 2 diabetes, and renoprotection. 145
How do we define cure of diabetes? 145
The protective effect of rosuvastatin in human umbilical endothelial cells exposed to constant or intermittent high glucose. 144
Glucose metabolism and hyperglycemia. 144
C-reactive protein is directly related to plasminogen activator inhibitor type 1 (PAI-1) levels in diabetic subjects with the 4G allele at position -675 of the PAI-1 gene. 144
Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus 144
Hyperglycemia-induced thrombin formation in diabetes. The possible role of oxidative stress 143
Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction. 143
Optimal dietary approaches for prevention of type 2 diabetes: a life-course perspective. 143
Long-term glycemic control influences the long-lasting effect of hyperglycemia on endothelial function in type 1 diabetes. 143
Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: the possible role of hyperglycemia 142
Possible role for increased C4b-binding-protein level in acquired protein S deficiency in type I diabetes. 142
Impaired insulin response to glucose but not to arginine in heroin addicts. 142
Lowering glucose to prevent adverse cardiovascular outcomes in a critical care setting. 142
Pramlintide reduced markers of oxidative stress in the postprandial period in patients with type 2 diabetes. 142
Non-enzymatic glycation reduces heparin cofactor II anti-thrombin activity. 142
Tolrestat in the primary prevention of diabetic neuropathy. 141
Effects of gliclazide beyond metabolic control. 141
Hyperglycemia-induced circulating ICAM-1 increase in diabetes mellitus: the possible role of oxidative stress. 141
The combined insulin and sulfonylurea therapy in diabetes of elderly people. 140
Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis. 140
The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: effects of rosiglitazone treatment. 140
Fibrinogen plasma levels as a marker of thrombin activation in diabetes. 139
Hyperglycemia may determine fibrinopeptide A plasma level increase in humans. 139
Increased glycation and oxidative damage to apolipoprotein B100 of LDL cholesterol in patients with type 2 diabetes and effect of metformin. 139
Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control. 139
Consensus algorithm of the American Diabetes Association and the European Association for the Study of Diabetes: some concerns. 139
Opiate addict as diabetic patient? 139
Pathogenetic loop between diabetes and cell senescence. 138
Increased alpha 2-macroglobulin in diabetes: a hyperglycemia related phenomenon associated with reduced antithrombin III activity. 138
Oxidative stress in diabetes. 137
The preventive anti-oxidant action of thiazolidinediones: a new therapeutic prospect in diabetes and insulin resistance. 137
Increased glycosylated haemoglobin A1 in opiate addicts: evidence for a hyperglycaemic effect of morphine. 136
Evidence for a hyperglycaemia-dependent decrease of antithrombin III-thrombin complex formation in humans. 136
The role of hyperglycaemia-induced alterations of antithrombin III and factor X activation in the thrombin hyperactivity of diabetes mellitus. 136
The importance of glycated haemoglobin (HbA(1c)) and postprandial glucose (PPG) control on cardiovascular outcomes in patients with type 2 diabetes. 136
Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes: a randomized trial. 136
Optimized postprandial glucose control is associated with improved cardiac/vascular function - comparison of three insulin regimens in well-controlled type 2 diabetes. 136
Antithrombin III and glycosylated hemoglobin in diabetic subjects 135
Totale 15.311
Salva come PNG Salva come JPEG
Categoria #
all - tutte 106.938
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.938
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021528 0 0 0 0 0 0 0 0 0 0 394 134
2021/20221.932 92 183 69 136 39 105 135 97 18 404 344 310
2022/20231.473 272 52 7 180 122 479 1 90 179 22 38 31
2023/2024324 51 30 9 5 53 47 3 10 83 14 3 16
2024/20254.209 46 292 49 81 50 159 227 192 415 603 640 1.455
2025/20266.535 333 764 710 983 859 521 718 258 390 683 316 0
Totale 33.232